# Opera Limited American (OPRA) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Technology / Software. Price $18.78, market value $1.7 billion.

## Valuation
- **P/E (trailing): 13.6×** (5-yr avg 17.8×, 3-yr avg 12.5×). Opera Limited American trades at 13.6× trailing earnings, well below its own five-year average of 17.8×: cheap by its own standards. The Technology median in the September 2026 study was 32.1×. Forward P/E is 10.5×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.33**. A PEG of 0.33 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 2.4×**. Each dollar of revenue is priced at 2.4×.
- **Price / book: 1.7×**. The shares trade at 1.7× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 8.9×**. Enterprise value is 8.9× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 6.8%** (5-yr avg 7.4%). Free cash flow equals 6.8% of the market value, in line with its five-year average of 7.4%. Above 5% is generally attractive.
- **Earnings yield: 7.3%**. The inverse of the P/E: 7.3% of the price is earned each year.

## Profitability
- **Gross margin: 63.2%**. Opera Limited American keeps 63.2% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 16.3%**. 16.3% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 17.6%**. 17.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 10.7%**. 10.7% on shareholders' equity is solid.
- **Return on invested capital: 10.9%**. Return on all capital, debt included, is 10.9%.
- **Return on assets: 11.1%**. Each dollar of assets produces 11.1% of profit.

## Growth
- **Revenue growth (1 yr): 27.9%** (3-yr 22.9%/yr, 5-yr 30.1%/yr). Revenue grew 27.9% over the last year, against 30.1% a year compounded over five years.
- **EPS growth (1 yr): 32.2%** (3-yr 104.1%/yr, 5-yr -17.0%/yr). Earnings per share rose 32.2%, roughly in step with revenue.
- **Free-cash-flow growth (3 yr): 28.0%/yr**. Free cash flow has compounded at 28.0% a year over three years, lagging earnings: check whether profits are turning into cash.

## Financial health
- **Debt to equity: 0.01**. Debt is 0.01 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. Opera Limited American holds more cash than debt.
- **Interest coverage: 241.6×**. Operating profit covers interest 241.6× over, a safe margin.
- **Current ratio: 2.35** (quick 2.35). Current assets cover the next year's liabilities 2.35 times.
- **Altman Z-score: 9.76**. A Z-score of 9.76 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 7/9**. 7 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend yield: 4.26%** ($0.80 per share, trailing). Opera Limited American yields 4.26%, an income-level yield.
- **Payout ratio: 66%**. 66% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 1**. 1 straight year of increases.

## Analyst view
- **Analyst consensus: strong_buy** (7 analysts). 7 analysts cover Opera Limited American; the consensus is strong_buy, with an average price target of $26.29 (+40% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 10.6%** (YTD 39.1%, 3-mo 5.4%). The shares are up 10.6% over twelve months including dividends.
- **From 52-week high: -10.8%** (60.4% above the low). Trading 11% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 46**. An RSI of 46 is neutral.
- **Beta (1 yr): 1.56** (volatility 51%). Beta of 1.56 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=OPRA · Page: https://foliofundamentals.com/stocks/opra

Not investment advice.